New biologic protects immunocompromised from COVID-19: studies
AstraZeneca’s long-acting monoclonal antibody can also be used to prevent disease progression, trials suggest.
AstraZeneca’s long-acting monoclonal antibody can also be used to prevent disease progression, trials suggest.
A selection of your views and stories posted on our website.
AusDoc marks 100 years since the discovery of a therapy that has saved the lives of millions.
The success of medical research has been one of the few positives of the COVID-19 pandemic. The effectiveness of vaccines in preventing deaths (see graph…
Professor Nikolai Petrovsky says he faces the sack if he doesn't get an exemption.
International experts have called out the poor quality of much research on faecal microbiota transplantation.
A selection of your views and stories posted on our website.
Think about how often we sense touch or temperature. Perhaps it’s the warmth we feel when we hold a coffee cup, or the comfort we…
Virologist Dr Vinod Balasubramaniam explains the interim trial results of the therapy in patients with mild to moderate disease.
A selection of your views and stories posted on our website.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.